SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601485-23-000071
Filing Date
2023-11-03
Accepted
2023-11-03 17:10:07
Documents
14
Period of Report
2023-11-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K angn-20231103.htm   iXBRL 8-K 23596
2 EX-99.1 eliciositcdatapr.htm EX-99.1 34070
6 image.jpg GRAPHIC 10516
  Complete submission text file 0001601485-23-000071.txt   211904

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20231103.xsd EX-101.SCH 1989
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20231103_lab.xml EX-101.LAB 25138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20231103_pre.xml EX-101.PRE 13130
8 EXTRACTED XBRL INSTANCE DOCUMENT angn-20231103_htm.xml XML 2816
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 231377301
SIC: 2834 Pharmaceutical Preparations